Colossal Laboratories & Biosciences
Operator of a bioscience and genetic engineering company committed to building radical new technologies to advance the f
Biotechnology
📍 Austin, TX
Founded 2021
Current Valuation
$10B
as of 2025-Q3
DECACORN
Operator of a bioscience and genetic engineering company committed to building radical new technologies to advance the field of genomics.
Company Profile
Last Round
Series C — $320M (Sep 2025)
Fundraising Status
Series C · $320M · 9 mo ago
privateTotal raised $558M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series C | $320M | Sep 2025 | — | $10B |
Health CareBiotechnologyLife ScienceGenetics
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2025-Q3. Refreshed quarterly.